Hims & Hers Health (HIMS) Total Current Liabilities (2019 - 2026)
Hims & Hers Health (HIMS) posted Total Current Liabilities of $618.8 million for Q1 2026, up 53.0% sequentially from $404.4 million in Q4 2025, and up 120.71% YoY from $280.4 million in Q1 2025.
Hims & Hers Health (HIMS) Total Current Liabilities (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Total Current Liabilities for 8 years, with the latest figure at $618.8 million in Q1 2026.
- Quarterly Total Current Liabilities rose 120.71% year-over-year to $618.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $618.8 million (up 120.71% YoY) and the FY2025 annual result came in at $404.4 million, up 82.7% from the prior year.
- Total Current Liabilities rose to $618.8 million in Q1 2026 per HIMS's latest filing, from $404.4 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $618.8 million in Q1 2026 and troughed at $47.9 million in Q4 2022.
- A 5-year average of $183.3 million and a median of $93.3 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities tumbled 39.48% in 2022, then soared 200.42% in 2025.
- Over 5 years, Total Current Liabilities stood at $47.9 million in 2022, then jumped by 84.54% to $88.5 million in 2023, then jumped by 150.22% to $221.4 million in 2024, then surged by 82.7% to $404.4 million in 2025, then surged by 53.0% to $618.8 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $618.8 million, $404.4 million, and $450.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Bn |
| Mar 31, 2026 | 618.78 Mn |
| Dec 31, 2025 | 404.43 Mn |
| Sep 30, 2025 | 450.79 Mn |
| Jun 30, 2025 | 272.23 Mn |
| Mar 31, 2025 | 280.36 Mn |
| Dec 31, 2024 | 221.37 Mn |
| Sep 30, 2024 | 152.65 Mn |
| Jun 30, 2024 | 108.67 Mn |
| Mar 31, 2024 | 93.32 Mn |
| Dec 31, 2023 | 88.47 Mn |
| Sep 30, 2023 | 82.55 Mn |
| Jun 30, 2023 | 66.55 Mn |
| Mar 31, 2023 | 56.28 Mn |
| Dec 31, 2022 | 47.94 Mn |
| Sep 30, 2022 | 66.82 Mn |
| Jun 30, 2022 | 55.62 Mn |
| Mar 31, 2022 | 48.50 Mn |
| Dec 31, 2021 | 79.22 Mn |
| Sep 30, 2021 | 52.50 Mn |